Evidence map›Paper›PMID 30305426›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

XBP1s activation can globally remodel N-glycan structure distribution patterns.

Madeline Y Wong, Kenny Chen, Aristotelis Antonopoulos, Brian T Kasper, Mahender B Dewal, Rebecca J Taylor, Charles A Whittaker, Pyae P Hein, Anne Dell, Joseph C Genereux and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Changes in tissue proteinPNAS nexus · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. What is the Sugar Code?Chembiochem : a European journal of chemical biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Madeline Y WongDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
Kenny ChenDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.ORCID 0000-0002-1939-9213
Aristotelis AntonopoulosDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Brian T KasperBiomedical Chemistry Institute, Department of Chemistry, New York University, New York, NY 10003.
Mahender B DewalDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
Rebecca J TaylorDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
Charles A WhittakerBarbara K. Ostrom (1978) Bioinformatics and Computing Facility, Massachusetts Institute of Technology, Cambridge, MA 02139.
Pyae P HeinDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
Anne DellDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Joseph C GenereuxDepartment of Chemistry, University of California, Riverside, CA 92521.
Stuart M HaslamDepartment of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom; s.haslam@imperial.ac.uk lkmahal@nyu.edu mshoulde@mit.edu.
Lara K MahalBiomedical Chemistry Institute, Department of Chemistry, New York University, New York, NY 10003; s.haslam@imperial.ac.uk lkmahal@nyu.edu mshoulde@mit.edu.ORCID 0000-0003-4791-8524
Matthew D ShouldersDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139; s.haslam@imperial.ac.uk lkmahal@nyu.edu mshoulde@mit.edu.
Massachusetts Institute of Technology · USImperial College London · GBNew York University · USUniversity of California, Riverside · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Angela Nicole Koehler · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza InfectionU01AI111598 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GHEDIN, ELODIE · 2013 to 2017
$13.3M
Proteostasis Network Factors Involved in Apolipoprotein B Folding and SecretionF32HL099245 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GENEREUX, JOSEPH · 2010 to 2012
$146k
Biotechnology and Biological Sciences Research Council BB/K016164/1NCI NIH HHS P30 CA014051NHLBI NIH HHS F32 HL099245NIAID NIH HHS U01 AI111598NIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

Classically, the unfolded protein response (UPR) safeguards secretory pathway proteostasis. The most ancient arm of the UPR, the IRE1-activated spliced X-box binding protein 1 (XBP1s)-mediated response, has roles in secretory pathway maturation beyond resolving proteostatic stress. Understanding the consequences of XBP1s activation for cellular processes is critical for elucidating mechanistic connections between XBP1s and development, immunity, and disease. Here, we show that a key functional output of XBP1s activation is a cell type-dependent shift in the distribution of N-glycan structures on endogenous membrane and secreted proteomes. For example, XBP1s activity decreased levels of sialylation and bisecting GlcNAc in the HEK293 membrane proteome and secretome, while substantially increasing the population of oligomannose N-glycans only in the secretome. In HeLa cell membranes, stress-independent XBP1s activation increased the population of high-mannose and tetraantennary N-glycans, and also enhanced core fucosylation. mRNA profiling experiments suggest that XBP1s-mediated remodeling of the N-glycome is, at least in part, a consequence of coordinated transcriptional resculpting of N-glycan maturation pathways by XBP1s. The discovery of XBP1s-induced N-glycan structural remodeling on a glycome-wide scale suggests that XBP1s can act as a master regulator of N-glycan maturation. Moreover, because the sugars on cell-surface proteins or on proteins secreted from an XBP1s-activated cell can be molecularly distinct from those of an unactivated cell, these findings reveal a potential new mechanism for translating intracellular stress signaling into altered interactions with the extracellular environment.

Indexed as

Cell LineCell Line, TumorHEK293 CellsHeLa CellsHumansMannosePolysaccharidesProteomeSignal TransductionTranscription, GeneticUnfolded Protein ResponseX-Box Binding Protein 1MannosePolysaccharidesProteomeX-Box Binding Protein 1XBP1 protein, humanendoplasmic reticulumglycoproteomelectin microarrayN-glycosylationproteostasis

Identifiers

PMID30305426
PMCPMC6205500
OpenAlexW2895883334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.